| 发明名称 |
IMMUNOTHERAPEUTIC DOSING REGIMENS AND COMBINATIONS THEREOF |
| 摘要 |
The invention described herein relates to therapeutic dosing regimens and combinations thereof for use in enhancing the therapeutic efficacy of immunotherapeutic agents e.g. CTLA-4 antagonists such as Ipilimumab or Tremelimumab in combination with one or more chemotherapeutic agents in cancer patients.
|
| 申请公布号 |
US2013064831(A1) |
申请公布日期 |
2013.03.14 |
| 申请号 |
US201113698300 |
申请日期 |
2011.05.16 |
| 申请人 |
HUMPHREY RACHEL WALLACH;BRISTOL-MYERS SQUIBB COMPANY |
发明人 |
HUMPHREY RACHEL WALLACH |
| 分类号 |
A61K39/395;A61P35/00;A61P37/02 |
主分类号 |
A61K39/395 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
